Abstract
Evidence of increased adverse event risk with systemic corticosteroid (SCS) use led patient management guidelines to embrace SCS-sparing treatment strategies. This study was conducted to describe time trends in SCS prescriptions and their relation to National Health Service (NHS) availability of SCS-sparing therapies.
Original language | English |
---|---|
Number of pages | 3 |
Publication status | Published - 19 Feb 2021 |
Event | BTS WINTER MEETING - Online Duration: 17 Feb 2021 → 20 Feb 2021 https://www.brit-thoracic.org.uk/education-and-events/winter-meeting-online/ |
Conference
Conference | BTS WINTER MEETING |
---|---|
Period | 17/02/21 → 20/02/21 |
Internet address |